931671366	931671366	CD	B-NP	O
|	|	NNP	I-NP	O
RH	RH	NNP	I-NP	O
|	|	VBD	B-VP	O
06109053	06109053	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
276286	276286	CD	B-NP	O
|	|	CC	I-NP	O
2/2/2002	2/2/2002	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
SCIATICA	SCIATICA	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/11/2002	10/11/2002	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/27/2002	3/27/2002	CD	B-NP	O
CHIEF	CHIEF	NN	I-NP	O
COMPLAINT	COMPLAINT	NN	I-NP	O
:	:	:	O	O
Sciatica	Sciatica	NNP	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
Forty-six-year-old	Forty-six-year-old	NNP	B-NP	O
fell	fall	VBD	B-VP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
bed	bed	NN	B-NP	O
yesterday	yesterday	NN	B-NP	O
reaching	reach	VBG	B-VP	O
for	for	IN	B-PP	O
something	something	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
fell	fall	VBD	B-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
coccyx	coccyx	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
loss	loss	NN	I-NP	O
of	of	IN	B-PP	O
consciousness	consciousness	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
head	head	NN	I-NP	O
trauma	trauma	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
get	get	VB	I-VP	O
up	up	RP	B-PRT	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
pain	pain	NN	B-NP	O
and	and	CC	I-NP	O
body	body	NN	I-NP	O
habitus	habitus	NN	I-NP	O
.	.	.	O	O

EMS	EMS	NNS	B-NP	O
was	be	VBD	B-VP	O
called	call	VBN	I-VP	O
and	and	CC	O	O
returned	return	VBN	B-VP	O
patient	patient	NN	B-NP	O
to	to	TO	B-PP	O
bed	bed	NN	B-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
refused	refuse	VBD	B-VP	O
to	to	TO	I-VP	O
come	come	VB	I-VP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
in	in	IN	B-PP	O
spite	spite	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
following	follow	VBG	I-NP	O
morning	morning	NN	I-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
still	still	RB	B-ADVP	O
with	with	IN	B-PP	O
consider	consider	VB	B-VP	O
lower	low	JJR	B-NP	O
back	back	NN	I-NP	O
and	and	CC	I-NP	O
buttock	buttock	NN	I-NP	O
pain	pain	NN	I-NP	O
radiating	radiate	VBG	B-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
right	right	JJ	I-NP	O
leg	leg	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
took	take	VBD	B-VP	O
her	her	PRP$	B-NP	O
normal	normal	JJ	I-NP	O
oxycodone	oxycodone	NN	I-NP	O
and	and	CC	I-NP	O
Vicodin	Vicodin	NN	I-NP	B-protein
doses	dose	NNS	I-NP	I-protein
without	without	IN	B-PP	I-protein
relief	relief	NN	B-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
EMS	EMS	NNP	B-NP	O
brought	bring	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
states	state	VBZ	B-VP	O
that	that	IN	B-SBAR	O
pain	pain	NN	B-NP	O
is	be	VBZ	B-VP	O
like	like	IN	B-PP	O
previous	previous	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
sciatica	sciatica	NN	B-NP	O
,	,	,	O	O
radicular	radicular	JJ	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
exacerbated	exacerbate	VBN	B-VP	O
by	by	IN	B-PP	O
her	her	PRP$	B-NP	O
fall	fall	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
department	department	NN	I-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-NP	O
,	,	,	I-NP	O
vital	vital	JJ	I-NP	O
signs	sign	NNS	I-NP	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
received	receive	VBD	B-VP	O
Ativan	Ativan	NNP	B-NP	O
,	,	,	O	O
Motrin	Motrin	NNP	B-NP	O
,	,	,	O	O
Dilaudid	Dilaudid	VBD	B-VP	O
with	with	IN	B-PP	O
little	little	JJ	B-NP	O
effect	effect	NN	I-NP	O
.	.	.	O	O

Plain	Plain	NN	B-NP	O
films	film	NNS	I-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
fracture	fracture	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
ambulate	ambulate	VB	I-VP	O
,	,	,	O	O
and	and	CC	O	O
therefore	therefore	RB	B-ADVP	O
admitted	admit	VBN	B-VP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
insulin-dependent	insulin-dependent	JJ	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
myocardial	myocardial	JJ	B-NP	O
infarction	infarction	NN	I-NP	O
non-Q-wave	non-Q-wave	JJ	I-NP	O
September	September	NNP	I-NP	O
,	,	,	O	O
2001	2001	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
MICU	MICU	NN	I-NP	O
admission	admission	NN	I-NP	O
during	during	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
September	September	NNP	B-NP	O
,	,	,	O	O
2001	2001	CD	B-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
urosepsis	urosepsis	NN	B-NP	O
,	,	,	O	O
diabetic	diabetic	JJ	B-NP	O
ketoacidosis	ketoacidosis	NN	I-NP	O
and	and	CC	O	O
this	this	DT	B-NP	O
non-Q-wave	non-Q-wave	JJ	I-NP	O
MI	MI	NN	I-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
,	,	,	O	O
sciatica	sciatica	NN	B-NP	O
with	with	IN	B-PP	O
previous	previous	JJ	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
herniated	herniate	VBN	I-NP	O
disc	disc	NN	I-NP	O
L5-S1	L5-S1	NN	I-NP	O
,	,	,	O	O
question	question	NN	B-NP	O
obstructive	obstructive	JJ	I-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
with	with	IN	B-PP	O
mild	mild	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
hypertension	hypertension	NN	I-NP	O
by	by	IN	B-PP	O
previous	previous	JJ	B-NP	O
echo	echo	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NN	B-NP	O
SURGICAL	SURGICAL	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Total	Total	JJ	B-NP	O
abdominal	abdominal	JJ	I-NP	O
hysterectomy	hysterectomy	NN	I-NP	O
and	and	CC	O	O
bilateral	bilateral	JJ	B-NP	O
salpingo-oophorectomy	salpingo-oophorectomy	NN	I-NP	O
complicated	complicate	VBN	B-VP	O
by	by	IN	B-PP	O
wound	wound	NN	B-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
Zocor	Zocor	NNP	B-NP	O
,	,	,	I-NP	O
Zestril	Zestril	NNP	I-NP	O
,	,	,	I-NP	O
aspirin	aspirin	NN	I-NP	O
,	,	,	I-NP	O
Toprol	Toprol	NN	I-NP	O
,	,	,	I-NP	O
morphine	morphine	NN	I-NP	O
,	,	,	I-NP	O
insulin	insulin	NN	I-NP	B-protein
and	and	CC	I-NP	O
Vicodin	Vicodin	NN	I-NP	O
.	.	.	O	O

STUDIES	STUDIES	NNS	B-NP	O
:	:	:	O	O
September	September	NNP	B-NP	O
,	,	,	O	O
2001	2001	CD	B-NP	O
,	,	,	O	O
MIBI	MIBI	NNP	B-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
old	old	JJ	I-NP	O
,	,	,	I-NP	O
moderately	moderately	RB	I-NP	O
sized	sized	JJ	I-NP	O
MI	MI	NN	I-NP	O
in	in	IN	B-PP	O
mid	mid	JJ	B-NP	O
LAD	LAD	NN	I-NP	O
distribution	distribution	NN	I-NP	O
with	with	IN	B-PP	O
moderate	moderate	JJ	B-NP	O
residual	residual	JJ	I-NP	O
peri-infarct	peri-infarct	JJ	I-NP	O
ischemia	ischemia	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
September	September	NNP	I-NP	O
,	,	,	O	O
2001	2001	CD	B-NP	O
,	,	,	O	O
echo	echo	NN	B-NP	O
showed	show	VBD	B-VP	O
left	left	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
hypokinesis	hypokinesis	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
inferior	inferior	JJ	I-NP	O
septum	septum	NN	I-NP	O
,	,	,	O	O
mildly	mildly	RB	B-ADVP	O
enlarged	enlarge	VBD	B-VP	O
RV	RV	NN	B-NP	O
,	,	,	O	O
pulmonary	pulmonary	JJ	B-NP	O
artery	artery	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
of	of	IN	B-PP	O
39	39	CD	B-NP	O
plus	plus	CC	O	O
RA	RA	NN	B-NP	O
,	,	,	O	O
suggestive	suggestive	JJ	B-ADJP	O
of	of	IN	B-PP	O
mild	mild	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
hypertension	hypertension	NN	I-NP	O
and	and	CC	O	O
mild	mild	JJ	B-NP	O
MR	MR	NN	I-NP	B-protein
and	and	CC	I-NP	O
TR	TR	NN	I-NP	B-protein
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
labs	lab	NNS	B-NP	O
were	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
glucose	glucose	NN	I-NP	O
of	of	IN	B-PP	O
121	121	CD	B-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	B-protein
1.4	1.4	CD	I-NP	I-protein
,	,	,	O	O
baseline	baseline	NN	B-NP	O
was	be	VBD	B-VP	O
one	one	CD	B-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
of	of	IN	B-PP	O
5.2	5.2	CD	B-NP	O
,	,	,	O	O
CK	CK	NN	B-NP	O
of	of	IN	B-PP	O
355	355	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
UA	UA	NNP	I-NP	O
with	with	IN	B-PP	O
plus	plus	CC	B-NP	O
two	two	CD	I-NP	O
leukocyte	leukocyte	NN	I-NP	B-protein
esterase	esterase	NN	I-NP	I-protein
,	,	,	O	O
85	85	CD	B-NP	O
whites	white	NNS	I-NP	O
,	,	,	O	O
plus	plus	CC	O	O
two	two	CD	B-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NN	B-NP	O
EXAM	EXAM	NN	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
had	have	VBD	B-VP	O
temperature	temperature	NN	B-NP	O
of	of	IN	B-PP	O
99	99	CD	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
67	67	CD	I-NP	O
,	,	,	O	O
respirations	respiration	NNS	B-NP	O
of	of	IN	B-PP	O
17	17	CD	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
130/50	130/50	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
saturation	saturation	NN	B-NP	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
obese	obese	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
head	head	NN	I-NP	O
trauma	trauma	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
neck	neck	NN	I-NP	O
was	be	VBD	B-VP	O
supple	supple	JJ	B-NP	O
,	,	,	I-NP	O
normal	normal	JJ	I-NP	O
S1	S1	NN	I-NP	O
,	,	,	O	O
S2	S2	NN	B-NP	B-protein
.	.	.	O	O

Her	Her	PRP$	B-NP	O
lungs	lung	NNS	I-NP	O
were	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
abdomen	abdomen	NN	I-NP	O
was	be	VBD	B-VP	O
markedly	markedly	RB	B-ADJP	O
obese	obese	JJ	B-NP	O
,	,	,	I-NP	O
positive	positive	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
,	,	,	O	O
nontender	nontender	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
skin	skin	NN	I-NP	O
abrasion	abrasion	NN	I-NP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
left	left	JJ	I-NP	O
elbow	elbow	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
spinal	spinal	JJ	I-NP	O
tenderness	tenderness	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
pelvic	pelvic	JJ	I-NP	O
tenderness	tenderness	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
raise	raise	VB	I-VP	O
her	her	PRP$	B-NP	O
right	right	JJ	I-NP	O
leg	leg	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-VP	O
pain	pain	VB	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
pain	pain	NN	B-NP	O
with	with	IN	B-PP	O
straight	straight	JJ	B-NP	O
leg	leg	NN	I-NP	O
left	leave	VBN	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
normal	normal	JJ	B-NP	O
sensation	sensation	NN	I-NP	O
in	in	IN	B-PP	O
upper	upper	JJ	B-NP	O
and	and	CC	I-NP	O
lower	low	JJR	I-NP	O
extremities	extremity	NNS	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
scheduled	schedule	VBN	I-VP	O
to	to	TO	I-VP	O
undergo	undergo	VB	I-VP	O
an	an	DT	B-NP	O
MRI	MRI	NN	I-NP	O
for	for	IN	B-PP	O
evaluation	evaluation	NN	B-NP	O
of	of	IN	B-PP	O
acutely	acutely	RB	B-NP	O
herniated	herniate	VBN	I-NP	O
disc	disc	NN	I-NP	O
at	at	IN	B-PP	O
an	an	DT	B-NP	O
outside	outside	JJ	I-NP	O
facility	facility	NN	I-NP	O
at	at	IN	B-PP	O
Y	Y	NNP	B-NP	O
Wau	Wau	NNP	I-NP	O
Topelum	Topelum	NNP	I-NP	O
,	,	,	O	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
not	not	RB	B-VP	O
being	be	VBG	I-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
fit	fit	VB	I-VP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
coils	coil	NNS	I-NP	O
at	at	IN	B-PP	O
our	our	PRP$	B-NP	O
own	own	JJ	I-NP	O
facility	facility	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
receive	receive	VB	I-VP	O
this	this	DT	B-NP	O
MRI	MRI	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
inability	inability	NN	B-NP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
assistance	assistance	NN	B-NP	O
with	with	IN	B-PP	O
transfer	transfer	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
reached	reach	VBD	B-VP	O
the	the	DT	B-NP	O
facility	facility	NN	I-NP	O
.	.	.	O	O

Initially	Initially	RB	B-ADVP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
pain	pain	NN	I-NP	O
was	be	VBD	B-VP	O
managed	manage	VBN	I-VP	O
with	with	IN	B-PP	O
both	both	CC	B-NP	O
immediate-release	immediate-release	JJ	I-NP	O
and	and	CC	I-NP	O
sustained-release	sustained-release	JJ	I-NP	O
morphine	morphine	NN	I-NP	O
and	and	CC	I-NP	O
Valium	Valium	NN	I-NP	O
for	for	IN	B-PP	O
spasm	spasm	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
received	receive	VBD	B-VP	O
around-the-clock	around-the-clock	JJ	B-NP	O
high-dose	high-dose	JJ	I-NP	O
NSAIDs	NSAID	NNS	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
by	by	IN	B-PP	O
physical	physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
and	and	CC	I-NP	O
nutrition	nutrition	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
UTI	UTI	NN	I-NP	B-DNA
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
Bactrim	Bactrim	NNP	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
three	three	CD	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
jumped	jump	VBD	B-VP	O
to	to	TO	B-PP	O
2.9	2.9	CD	B-NP	O
from	from	IN	B-PP	O
1.4	1.4	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
hyperkalemic	hyperkalemic	JJ	B-ADJP	O
to	to	TO	B-PP	O
5.9	5.9	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
NSAIDs	NSAID	NNS	I-NP	O
were	be	VBD	B-VP	O
stopped	stop	VBN	I-VP	O
and	and	CC	O	O
Neurontin	Neurontin	NN	B-NP	B-protein
was	be	VBD	B-VP	O
DCed	DCe	VBN	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
somnolence	somnolence	NN	B-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
worsening	worsen	VBG	I-VP	O
renal	renal	JJ	B-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
and	and	CC	I-NP	O
somnolence	somnolence	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
blood	blood	NN	B-NP	O
gas	gas	NN	I-NP	O
showed	show	VBD	B-VP	O
primary	primary	JJ	B-NP	O
respiratory	respiratory	JJ	I-NP	O
acidosis	acidosis	NN	I-NP	O
,	,	,	O	O
hypercarbia	hypercarbia	NN	B-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
ultimately	ultimately	RB	I-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
MICU	MICU	NN	I-NP	B-DNA
for	for	IN	B-PP	O
intubation	intubation	NN	B-NP	O
for	for	IN	B-PP	O
airway	airway	NN	B-NP	O
protection	protection	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
aspiration	aspiration	NN	B-NP	O
.	.	.	O	O

By	By	IN	B-PP	O
April	April	NNP	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
had	have	VBD	B-VP	O
returned	return	VBN	I-VP	O
to	to	TO	B-PP	O
baseline	baseline	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
extubated	extubate	VBN	I-VP	O
without	without	IN	B-PP	O
complications	complication	NNS	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
renal	renal	JJ	I-NP	O
function	function	NN	I-NP	O
was	be	VBD	B-VP	O
presumed	presume	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
secondary	secondary	JJ	B-NP	O
high-dose	high-dose	JJ	I-NP	O
NSAIDs	NSAID	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
intubation	intubation	NN	I-NP	O
was	be	VBD	B-VP	O
deemed	deem	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
primary	primary	JJ	I-NP	O
respiratory	respiratory	JJ	I-NP	O
acidosis	acidosis	NN	I-NP	O
from	from	IN	B-PP	O
opioid	opioid	JJ	B-NP	O
intoxication	intoxication	NN	I-NP	O
exacerbated	exacerbate	VBN	B-VP	O
by	by	IN	B-PP	O
renal	renal	JJ	B-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

Issues	Issue	NNS	B-NP	O
are	be	VBP	B-VP	O
as	as	IN	B-SBAR	O
follows	follow	NNS	B-NP	O
by	by	IN	B-PP	O
systems	system	NNS	B-NP	O
:	:	:	O	O
Pulmonary	Pulmonary	JJ	B-ADJP	O
:	:	:	O	O
Overnight	Overnight	JJ	B-NP	O
pulse	pulse	NN	I-NP	O
oximetry	oximetry	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
,	,	,	O	O
which	which	WDT	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
analyzed	analyze	VBN	I-VP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
for	for	IN	B-PP	O
obstructive	obstructive	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
will	will	MD	B-VP	O
most	most	RBS	B-ADVP	O
likely	likely	RB	I-ADVP	O
need	need	VBP	B-VP	O
a	a	DT	B-NP	O
form	form	NN	I-NP	O
of	of	IN	B-PP	O
sleep	sleep	JJ	B-NP	O
study	study	NN	I-NP	O
at	at	IN	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
or	or	CC	B-PP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
to	to	TO	B-VP	O
address	address	VB	I-VP	O
this	this	DT	B-NP	O
obstructive	obstructive	JJ	I-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
issue	issue	NN	I-NP	O
.	.	.	O	O

Data	Datum	NNS	B-NP	O
from	from	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
support	support	VB	I-VP	O
a	a	DT	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
obesity	obesity	NN	B-NP	O
hypoventilation	hypoventilation	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
,	,	,	O	O
because	because	IN	B-SBAR	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
daytime	daytime	NN	I-NP	O
hypercapnia	hypercapnia	NN	I-NP	O
by	by	IN	B-PP	O
both	both	CC	O	O
ABGs	ABG	NNS	B-NP	O
and	and	CC	O	O
Chem-7	Chem-7	NN	B-NP	O
panel	panel	NN	I-NP	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
Acute	Acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
resolved	resolve	VBN	B-VP	O
with	with	IN	B-PP	O
hydration	hydration	NN	B-NP	O
,	,	,	O	O
withdrawal	withdrawal	NN	B-NP	O
of	of	IN	B-PP	O
NSAIDs	NSAID	NNS	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
will	will	MD	B-VP	O
hold	hold	VB	I-VP	O
her	her	PRP$	B-NP	O
ACE	ACE	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
recent	recent	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
this	this	DT	B-NP	O
evaluated	evaluate	VBN	B-VP	O
in	in	IN	B-PP	O
two	two	CD	B-NP	O
weeks	week	NNS	I-NP	O
or	or	CC	I-NP	O
so	so	RB	I-NP	O
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
disease	disease	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
low-grade	low-grade	JJ	B-NP	O
fevers	fever	NNS	I-NP	O
on	on	IN	B-PP	O
empiric	empiric	JJ	B-NP	O
Levofloxacin	Levofloxacin	NN	I-NP	O
and	and	CC	I-NP	O
Flagyl	Flagyl	NN	I-NP	O
day	day	NN	I-NP	O
seven	seven	CD	I-NP	O
of	of	IN	B-PP	O
14	14	CD	B-NP	O
for	for	IN	B-PP	O
aspiration	aspiration	NN	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
suffered	suffer	VBN	B-VP	O
during	during	IN	B-PP	O
hypocarbic	hypocarbic	JJ	B-NP	O
respiratory	respiratory	JJ	I-NP	O
arrest	arrest	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
two	two	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
,	,	,	O	O
after	after	IN	B-PP	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
blood	blood	NN	I-NP	O
cultures	culture	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ICU	ICU	NN	I-NP	B-protein
grew	grow	VBD	B-VP	I-protein
coagulase	coagulase	NN	B-NP	I-protein
negative	negative	JJ	I-NP	O
Staph	Staph	NNP	I-NP	O
.	.	.	O	O

All	All	DT	B-NP	O
cultures	culture	NNS	I-NP	O
since	since	IN	B-PP	O
then	then	RB	B-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
two	two	CD	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
liquid	liquid	JJ	B-NP	O
stool	stool	NN	I-NP	O
on	on	IN	B-PP	O
Flagyl	Flagyl	NN	B-NP	O
,	,	,	O	O
day	day	NN	B-NP	O
six	six	CD	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
already	already	RB	I-VP	O
receiving	receive	VBG	I-VP	O
therapy	therapy	NN	B-NP	O
for	for	IN	B-PP	O
C.	C.	NNP	B-NP	O
difficile	difficile	NNP	I-NP	O
.	.	.	O	O

Because	Because	IN	B-SBAR	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
three	three	CD	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
an	an	DT	B-NP	O
O	O	NNP	I-NP	O
&	&	CC	I-NP	O
P	P	NNP	I-NP	O
is	be	VBZ	B-VP	O
very	very	RB	B-NP	O
low	low	JJ	I-NP	O
yield	yield	NN	I-NP	O
.	.	.	O	O

Stool	Stool	NN	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
and	and	CC	O	O
a	a	DT	B-NP	O
repeat	repeat	NN	I-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
done	do	VBN	I-VP	O
if	if	IN	B-SBAR	O
clinical	clinical	JJ	B-NP	O
worsens	worsen	NNS	I-NP	O
tomorrow	tomorrow	NN	B-NP	O
.	.	.	O	O

Neurologic	Neurologic	JJ	B-ADJP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
with	with	IN	B-PP	O
known	know	VBN	B-NP	O
small	small	JJ	I-NP	O
right	right	JJ	I-NP	O
lateral	lateral	JJ	I-NP	O
recess	recess	NN	I-NP	O
disc	disc	NN	I-NP	O
herniation	herniation	NN	I-NP	O
impinging	impinge	VBG	B-VP	O
on	on	IN	B-PP	O
right	right	JJ	B-NP	O
nerve	nerve	NN	I-NP	O
root	root	NN	I-NP	O
at	at	IN	B-PP	O
L5-S1	L5-S1	NN	B-NP	B-DNA
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
previous	previous	JJ	B-NP	O
received	receive	VBN	I-NP	O
steroid	steroid	NN	I-NP	O
injections	injection	NNS	I-NP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
refused	refuse	VBN	I-VP	O
surgery	surgery	NN	B-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
very	very	RB	B-NP	O
bad	bad	JJ	I-NP	O
experience	experience	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
total	total	JJ	I-NP	O
abdominal	abdominal	JJ	I-NP	O
hysterectomy	hysterectomy	NN	I-NP	O
complicated	complicate	VBN	B-VP	O
by	by	IN	B-PP	O
wound	wound	NN	B-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
an	an	DT	B-NP	O
acute	acute	JJ	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
pain	pain	NN	I-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
fall	fall	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
were	be	VBD	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
obtain	obtain	VB	I-VP	O
an	an	DT	B-NP	O
MRI	MRI	NN	I-NP	O
at	at	IN	B-PP	O
outside	outside	JJ	B-NP	O
facility	facility	NN	I-NP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
her	her	PRP$	B-NP	O
body	body	NN	I-NP	O
habitus	habitus	NN	I-NP	O
and	and	CC	I-NP	O
need	need	NN	I-NP	O
for	for	IN	B-PP	O
assistance	assistance	NN	B-NP	O
with	with	IN	B-PP	O
movement	movement	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
would	would	MD	B-VP	O
benefit	benefit	VB	I-VP	O
from	from	IN	B-PP	O
aggressive	aggressive	JJ	B-NP	O
PT	PT	NN	I-NP	O
and	and	CC	O	O
pain	pain	NN	B-NP	O
control	control	NN	I-NP	O
with	with	IN	B-PP	O
eventual	eventual	JJ	B-NP	O
surgery	surgery	NN	I-NP	O
if	if	IN	B-SBAR	O
these	these	DT	B-NP	O
more	more	RBR	I-NP	O
conservative	conservative	JJ	I-NP	O
measures	measure	NNS	I-NP	O
fail	fail	VBP	B-VP	O
.	.	.	O	O

Pain	Pain	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
oversedated	oversedate	VBN	I-VP	O
on	on	IN	B-PP	O
pain	pain	NN	B-NP	O
medications	medication	NNS	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
actually	actually	RB	I-VP	O
intubated	intubate	VBN	I-VP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
need	need	NN	I-NP	O
to	to	TO	B-VP	O
balance	balance	VB	I-VP	O
desire	desire	NN	B-NP	O
to	to	TO	B-VP	O
alleviate	alleviate	VB	I-VP	O
pain	pain	NN	B-NP	O
with	with	IN	B-PP	O
need	need	NN	B-NP	O
for	for	IN	B-PP	O
patient	patient	NN	B-NP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
adequate	adequate	JJ	B-NP	O
respiratory	respiratory	JJ	I-NP	O
drive	drive	NN	I-NP	O
.	.	.	O	O

Endocrine	Endocrine	NNP	B-NP	O
:	:	:	O	O
Continue	Continue	JJ	B-NP	O
NPH	NPH	NN	I-NP	O
and	and	CC	I-NP	O
CZI	CZI	NN	I-NP	O
and	and	CC	I-NP	O
ADA	ADA	NN	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

Will	Will	NNP	B-NP	O
begin	begin	VB	B-VP	O
Meridia	Meridia	NNP	B-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
also	also	RB	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
nutrition	nutrition	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
number	number	NN	B-NP	O
for	for	IN	B-PP	O
weight	weight	NN	B-NP	O
loss	loss	NN	I-NP	O
program	program	NN	I-NP	O
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
Non-Q-wave	Non-Q-wave	JJ	B-NP	O
MI	MI	NN	I-NP	O
in	in	IN	B-PP	O
September	September	NNP	B-NP	O
,	,	,	O	O
2001	2001	CD	B-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
with	with	IN	B-PP	O
preserved	preserve	VBN	B-NP	O
EF	EF	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
valve	valve	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Will	Will	MD	B-VP	O
continue	continue	VB	I-VP	O
current	current	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

Will	Will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
restart	restart	VB	I-VP	O
ACE	ACE	NN	B-NP	O
inhibitor	inhibitor	NN	I-NP	O
in	in	IN	B-PP	O
two	two	CD	B-NP	O
to	to	TO	I-NP	O
three	three	CD	I-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
now	now	RB	B-ADVP	O
that	that	IN	B-SBAR	O
renal	renal	JJ	B-NP	O
failure	failure	NN	I-NP	O
resolved	resolve	VBN	B-VP	O
.	.	.	O	O

Prophylaxis	Prophylaxis	NN	B-NP	O
:	:	:	O	O
Subcutaneous	Subcutaneous	JJ	B-NP	O
Heparin	Heparin	NN	I-NP	O
,	,	,	O	O
Protime	Protime	NN	B-NP	O
pump	pump	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Dulcolax	Dulcolax	NN	B-NP	O
and	and	CC	I-NP	O
Lactulose	Lactulose	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
for	for	IN	B-PP	O
constipation	constipation	NN	B-NP	O
while	while	IN	B-SBAR	O
on	on	IN	B-PP	O
narcotics	narcotic	NNS	B-NP	O
.	.	.	O	O

Social	Social	JJ	B-ADJP	O
:	:	:	O	O
I	I	PRP	B-NP	O
have	have	VBP	B-VP	O
written	write	VBN	I-VP	O
a	a	DT	B-NP	O
letter	letter	NN	I-NP	O
regarding	regard	VBG	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
need	need	NN	I-NP	O
for	for	IN	B-PP	O
first-floor	first-floor	JJ	B-NP	O
apartment	apartment	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
inability	inability	NN	B-NP	O
to	to	TO	B-VP	O
use	use	VB	I-VP	O
stairs	stair	NNS	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
chart	chart	NN	I-NP	O
.	.	.	O	O

Additional	Additional	JJ	B-NP	O
comments	comment	NNS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	O
monitor	monitor	NN	I-NP	O
patient	patient	NN	I-NP	O
carefully	carefully	RB	B-ADVP	O
for	for	IN	B-PP	O
oversedation	oversedation	NN	B-NP	O
on	on	IN	B-PP	O
current	current	JJ	B-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
sleep	sleep	JJ	B-NP	O
study	study	NN	I-NP	O
to	to	TO	B-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
obstructive	obstructive	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-ADJP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Tylenol	Tylenol	NN	B-NP	O
650	650	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.	q.	NN	I-NP	O
six	six	CD	B-NP	O
hours	hour	NNS	I-NP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
,	,	,	O	O
Albuterol	Albuterol	NNP	B-NP	O
nebulizer	nebulizer	NN	I-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
nebulizer	nebulizer	NN	I-NP	O
q.	q.	NN	I-NP	O
four	four	CD	B-NP	O
hours	hour	NNS	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
wheeze	wheeze	NN	I-NP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
enteric-coated	enteric-coated	JJ	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Dulcolax	Dulcolax	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.r.	p.r.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
constipation	constipation	NN	I-NP	O
,	,	,	O	O
Valium	Valium	NN	B-NP	O
five	five	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	FW	I-NP	O
muscle	muscle	NN	I-NP	O
spasm	spasm	NN	I-NP	O
,	,	,	O	O
hold	hold	VBP	B-VP	O
if	if	IN	B-SBAR	O
oversedation	oversedation	NN	B-NP	O
or	or	CC	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
10	10	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
call	call	NN	B-NP	O
HO	HO	NN	I-NP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
fentanyl	fentanyl	NN	B-NP	O
patch	patch	NN	I-NP	O
50	50	CD	I-NP	O
mcg	mcg	NN	I-NP	O
per	per	IN	B-PP	O
hour	hour	NN	B-NP	O
t.p.	t.p.	NN	I-NP	O
q.	q.	NN	I-NP	O
72	72	CD	B-NP	O
hours	hour	NNS	I-NP	O
,	,	,	O	O
hold	hold	VBP	B-VP	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
10	10	CD	I-NP	O
,	,	,	O	O
oversedation	oversedation	NN	B-NP	O
,	,	,	O	O
Heparin	Heparin	NN	B-NP	B-protein
10	10	CD	I-NP	I-protein
,	,	,	I-NP	O
000	000	CD	I-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
b.i.d.	b.i.d.	RB	I-ADVP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	B-protein
Humulin	Humulin	NN	I-NP	I-protein
insulin	insulin	NN	I-NP	I-protein
35	35	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
q.a.m.	q.a.m.	RB	B-ADVP	O
,	,	,	O	O
25	25	CD	B-NP	O
units	unit	NNS	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
,	,	,	O	O
hold	hold	VBP	B-VP	O
if	if	IN	B-SBAR	O
blood	blood	NN	B-NP	O
sugar	sugar	NN	I-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
100	100	CD	B-NP	O
,	,	,	O	O
CZI	CZI	NN	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
sugars	sugar	NNS	I-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
200	200	CD	B-NP	O
give	give	VB	B-VP	O
0	0	CD	B-NP	O
units	unit	NNS	I-NP	O
,	,	,	O	O
if	if	IN	B-SBAR	O
blood	blood	NN	B-NP	O
sugar	sugar	NN	I-NP	O
is	be	VBZ	B-VP	O
201	201	CD	B-NP	O
to	to	TO	B-PP	O
250	250	CD	B-NP	O
,	,	,	O	O
give	give	VB	B-VP	O
four	four	CD	B-NP	O
units	unit	NNS	I-NP	O
,	,	,	O	O
if	if	IN	B-SBAR	O
blood	blood	NN	B-NP	O
sugar	sugar	NN	I-NP	O
is	be	VBZ	B-VP	O
251	251	CD	B-NP	O
to	to	TO	B-PP	O
300	300	CD	B-NP	O
,	,	,	O	O
give	give	VB	B-VP	O
six	six	CD	B-NP	O
units	unit	NNS	I-NP	O
,	,	,	O	O
if	if	IN	B-SBAR	O
blood	blood	NN	B-NP	O
sugar	sugar	NN	I-NP	O
is	be	VBZ	B-VP	O
301	301	CD	B-NP	O
to	to	TO	B-PP	O
350	350	CD	B-NP	O
give	give	VB	B-VP	O
eight	eight	CD	B-NP	O
units	unit	NNS	I-NP	O
,	,	,	O	O
if	if	IN	B-SBAR	O
blood	blood	NN	B-NP	O
sugar	sugar	NN	I-NP	O
is	be	VBZ	B-VP	O
351	351	CD	B-NP	O
to	to	TO	B-PP	O
400	400	CD	B-NP	O
give	give	VB	B-VP	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
and	and	CC	O	O
call	call	VB	B-VP	O
house	house	NN	B-NP	O
officer	officer	NN	I-NP	O
,	,	,	O	O
magnesium	magnesium	NN	B-NP	O
gluconate	gluconate	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Lopressor	Lopressor	NNP	B-NP	O
,	,	,	O	O
Metoprolol	Metoprolol	NNP	B-NP	O
tartrate	tartrate	VBP	B-VP	O
37.5	37.5	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.i.d.	q.i.d.	FW	I-ADVP	O
,	,	,	O	O
hold	hold	VBP	B-VP	O
systolic	systolic	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
90	90	CD	B-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
55	55	CD	B-NP	O
,	,	,	O	O
Flagyl	Flagyl	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
x	x	SYM	B-VP	O
seven	seven	CD	B-NP	O
more	more	JJR	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
oxycodone	oxycodone	NN	B-NP	B-protein
10	10	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	NN	I-NP	I-protein
q.	q.	NN	I-NP	I-protein
six	six	CD	B-NP	I-protein
hours	hour	NNS	I-NP	I-protein
p.r.n.	p.r.n.	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
,	,	,	O	O
hold	hold	NN	B-NP	O
oversedation	oversedation	NN	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
10	10	CD	I-NP	O
,	,	,	O	O
Senna	Senna	NNP	B-NP	O
tablets	tablet	VBZ	B-VP	O
two	two	CD	B-NP	O
tablets	tablet	NNS	I-NP	O
p.o.	p.o.	FW	I-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
p.r.n.	p.r.n.	FW	I-NP	O
constipation	constipation	NN	I-NP	O
,	,	,	O	O
Zocor	Zocor	NNP	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
Neurontin	Neurontin	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
hold	hold	NN	B-NP	O
oversedation	oversedation	NN	I-NP	O
,	,	,	O	O
levofloxacin	levofloxacin	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
x	x	SYM	O	O
seven	seven	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
Micolazole	Micolazole	NN	B-NP	O
two-percent	two-percent	JJ	I-NP	O
powder	powder	NN	I-NP	O
topical	topical	JJ	I-NP	O
t.p.	t.p.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
instructions	instruction	NNS	B-NP	O
-	-	:	O	O
place	place	NN	B-NP	O
in	in	IN	B-PP	O
skin	skin	NN	B-NP	O
folds	fold	NNS	I-NP	O
,	,	,	O	O
Nexium	Nexium	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Trazodone	Trazodone	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.h.s.	q.h.s.	FW	I-NP	O
p.r.n.	p.r.n.	FW	I-NP	O
sleep	sleep	NN	I-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
MARCELINO	MARCELINO	NNP	B-NP	O
BARTZ	BARTZ	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
WE48	WE48	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
HAROLD	HAROLD	NNP	B-NP	O
WILSHUSEN	WILSHUSEN	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
IU98	IU98	NNP	I-NP	O
LD753/752112	LD753/752112	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
0655	0655	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

UTZCGI18I6	UTZCGI18I6	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
10/8/02	10/8/02	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
1/6/02	1/6/02	CD	B-NP	O

